Rare genetic diseases are proving to be an increasingly lucrative market for drug developers. However, it is a niche with many unique challenges to overcome.
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
This week’s big story brings genomics to pub conversations in the UK.
Poll results and analysis. Bioinformaticians still a preciously limited resource.
Genome sequencing and ward information were used to control the Acinetobacter baumannii outbreak in Birmingham.
Illumina, USAID, and Broad Institute form partnership to help fight Ebola in West Africa.
What do we need most, to keep genomics moving?
As new genomic information becomes available, is the clinic duty bound to inform patients who might be affected?